New York University Langone Medical Center - Perlmutter Cancer Center

333 East 38th Street
New York, New York 10016

We've found

2 trials

at this facility

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

New York, NY

A Study of Parsaclisib in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New York, NY

Use our guide to learn which trials are right for you!